This clinical trial is focused on studying infertility and involves a treatment approach for women who are preserving their fertility. The study is comparing two different methods of stimulating the ovaries to produce mature eggs. The first method involves two doses of a medication called Corifollitropin Alfa (CFA), while the second method uses one dose of CFA followed by daily doses of another medication called recombinant Follicle Stimulating Hormone (rFSH). These medications are used to help the ovaries produce more eggs, which can then be collected and preserved for future use.

The purpose of the study is to compare the number of mature eggs retrieved using these two different methods. Participants will receive either the two doses of CFA or the combination of CFA and rFSH. The study will also look at other factors, such as the total number of eggs collected, hormone levels on the day of egg collection, and any side effects like Ovarian Hyperstimulation Syndrome (OHSS), which is a condition where the ovaries become swollen and painful. Additionally, participants will complete a quality of life questionnaire to assess their experience during the study.

The study will take place over a period of time, with participants undergoing the treatment and monitoring process. This includes receiving the medications, attending appointments for blood tests, and having the eggs collected. The goal is to determine which method is more effective in helping women preserve their fertility by producing a higher number of mature eggs.